Antiplasmodial activity of artecyclopentyl mether a new artemisinin derivative and its effect on pathogenesis in Plasmodium yoelii nigeriensis infected mice

Parasitology Research

Volumn 109, Issue 4, 2011, Pages 1003-1008

  Agarwal, Jyoti ^a   Singh, Suriya Pratap ^a   Chanda, Debabrata ^a   Bawankule, Dnyaneshwar Umrao ^a   Bhakuni, Rajendra Singh ^a   Pal, Anirban ^a  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTECYCLOPENTYL METHER; ARTEETHER; ARTEMISININ DERIVATIVE; CPM 1; GAMMA INTERFERON; GLUCOSE; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 4; NITRIC OXIDE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; FEMALE; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLASMODIUM YOELII INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CYTOKINES; DRUG RESISTANCE, MULTIPLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; FEMALE; LIPID PEROXIDATION; MALARIA; MICE; NITRIC OXIDE; OXIDATIVE STRESS; PARASITEMIA; PLASMODIUM YOELII; RODENT DISEASES; SURVIVAL RATE;

MUS; PLASMODIUM YOELII NIGERIENSIS;

EID: 83155175346     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-011-2344-1     Document Type: Article

References (31)

1. Bhakuni RS, Jain DC, Sharma RP (1995) An improved procedure for the synthesis of ethers of di-hydroartemisinin. Indian J Chem B Org 34b:529-530
2. Brossi A, Venugopalan B, Gerpe LD, Yeh HJC, Flippen-Anderson JL, Buchs P, Luo XD, Milhous W, Peters W (1988) Arteether, a new antimalarial drug: synthesis and antimalarial properties. J Med Chem 31:645-650 (Pubitemid 18070586)
3. Chanda D, Shanker K, Pal A, Luqman S, Bawankule DU, Mani DN, Darokar MP (2009) Safety evaluation of Trikatu a generic ayurvedic medicine in Charles Foster rats. J Toxicol Sci 34:99-108
4. Clark IA (2007) How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev 18:335-343 (Pubitemid 46891287)
5. Clark IA, Chaudhri G (1988) Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Haematol 70:90-99
6. Clark IA, Virelizier JL, Carswell EA, Wood PR (1981) Possible importance of macrophage derived mediators in acute malaria. Infect Immun 32:1058-1066 (Pubitemid 11109808)
7. Clark IA, Rockett KA, Cowden WB (1991) Proposed link between cytokines, nitric acid and human cerebral malaria. Parasitol Today 7:205-207 (Pubitemid 121002773)
8. Clark IA, Budd AC, Alleva LM, Cowden WB (2006) Human malarial disease: a consequence of inflammatory cytokine release. Malar J 5:85-117
9. Dinarello CA (1987) Interleukins, tumour necrosis fators (cachectin), and interferons as endogenous pyrogens and mediators of fever. Lymphokines 14:1-31
10. Dinarello CA, Caannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA, O'Connor JV (1986) Tumour necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J Exp Med 163:1433-1450 (Pubitemid 16043463)
11. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ (2009) Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361:455-467
12. Duffy PE, Mutabingwa TK (2004) Drug combinations for malaria: time to ACT. Lancet 363:3-4 (Pubitemid 38076914)
13. Dutta GP, Bajpai R, Vishwakarma RA (1989) Antimalarial efficacy of arteether against multiple drug resistant strain of Plasmodium yoelii nigeriensis. Pharmacol Res 21:415-419 (Pubitemid 19206250)
14. Elased KM, Taverne J, Playfair JH (1996) Malaria, blood glucose, and the role of tumour necrosis factor (TNF) in mice. Clin Exp Immunol 105:443-449 (Pubitemid 26297888)
15. Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S (2004) Antimalarial drug discovery: efficacy models for compound screening. Nat Rev Drug Discov 3:509-520 (Pubitemid 38807533)
16. Foley M, Tilley L (1998) Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol Ther 79:55-87 (Pubitemid 28318262)
17. Khanuja SPS, Paul S, Shasany AK, Gupta AK, Darokar MP, Gupta MM, Verma RK, Ram G, Kumar A, Lal RK, Bansal RP, Singh AK, Bhakuni RS, Tandon S (2008) High artemisinin yielding plant named "CIM-arogya" US Patent 7,375,260
18. Mshana N, Boulandi J, Mshana NM, Mayombo J, Mendome G (1991) Cytokines in the pathogenesis of malaria: levels of IL-1 beta, IL-4, IL-6, TNF-alpha and IFN-gamma in plasma of healthy individuals and malaria patients in a holoendemic area. J Clin Lab Immunol 34:134-139
19. Oppenheimer SJ (1989) Iron and malaria. Parasitol Today 5:77-82
20. Pandey AV, Tekwani BL, Singh RL, Chauhan VS (1999) Artemisinin an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite. J Biol Chem 247:19383-19388
21. Peters W, Howells RE, Portus J, Robinson BL, Thomas S, Warhurst DC (1977) The chemotherapy of rodent malaria, XXVII. Studies on mefloquine (WR 142,490). Ann Trop Med Parasitol 71:407-418 (Pubitemid 8216711)
22. Peters W, Robinson BL, Ellis DS (1987) The chemotherapy of rodent malaria, XLII. Halofantrine and halofantrine resistance. Ann Trop Med Parastitol 81:639-646 (Pubitemid 18077358)
23. Posner GH, Paik H, Sur S, McRiner AJ, Borstnik K, Xie S, Shapiro TA (2003) Orally active, antimalarial, anticancer, artemisininderived trioxane dimers with high stability and efficacy. J Med Chem 46:1060-1065 (Pubitemid 36423152)
24. Schofield L, Grau GE (2005) Immunological processes in malaria pathogenesis. Nat Rev Immunol 5:722-735 (Pubitemid 43086173)
25. Singh N, Puri SK (2000) Modulation of halofantrine resistance after coadministration of halofantrine with diverse pharmacological agents in a rodent malaria model. Life Sci 67:1345-1354 (Pubitemid 30640822)
26. Singh C, Chaudhary S, Puri SK (2008) Orally active esters of dihydroartemisinin: synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in mice. Bioorg Med Chem Lett 18:1436-1441 (Pubitemid 351233030)
27. Stevenson MM, Riley EM (2004) Innate immunity to malaria. Nat Rev Immunol 4:169-180 (Pubitemid 38339083)
28. Vennerstrom JL, Dong Y, Andersen SL, Ager AL, Fu H, Miller RE, Wesche DL, Kyle DE, Gerena L, Walters SM, Wood JK, Edwards G, Holme AD, McLean WG, Milhous WK (2000) Synthesis and antimalarial activity of sixteen dispiro-1,2,4, 5-tetraoxanes: alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5. 2] hexadecanes. J Med Chem 43:2753-2758 (Pubitemid 30463924)
29. Verra F, Luoni G, Calissano C, Troye-Blomberg M, Perlmann P, Perlmann H, Arcà B, Sirima BS, Konate A, Coluzzi M, Kwiatkowski D, Modiano D (2004) IL4-589C/T polymorphism and IgE levels in severe malaria. Acta Trop 90:205-209 (Pubitemid 38283770)
30. Wahlgren M, Perlmann P (1999) Malaria: molecular and clinical aspects. Harwood academic publishers, Netherlands WHO (2010) Guidelines for the treatment of malaria. 2nd edn. http://whqlibdoc.who.int/publications/2010/9789241547925- eng.pdf
31. Xie YW, Wolin MS (1996) Role of nitric oxide and its interaction with superoxide in the suppression of cardiac muscle mitochondrial respiration. Involvement in response to hypoxia/reoxygenation. Circulation 94:2580-2586 (Pubitemid 26403589)